Reduction in IL‐1β, IL‐6, TNF‐α, PGE2, and MIP‐1‐α in microglia (1, 10, and 25 μM) VCE‐003 ameliorated MS symptoms induced by TMEV. The gene discussed is CCL3; the disease is myeloid sarcoma.